0521779407-15 CUNY1086/Karliner 0 521 77940 7 June 7, 2007 18:43
1058 Nongranulomatous Systemic Vasculitis
➣Assoc w/ rheumatic disease (eg, SLE, rheumatoid arthritis, Sjo-
gren syndrome)
■Cholesterol, mycotic emboli
■Drug reactions
■Atrial myxoma
■Serum sickness
■Systemic amyloidosis
■Familial Mediterranean fever
management
What to Do First
■Assess extent & severity of vascular disease
■Control blood pressure; assessment of end-organ vascular integrity
■In cases of threatened organs (eg, abdominal angina w/ PAN, rapidly
progressive glomerulonephritis, CNS disease or rapidly progressive
mononeuritis multiplex, pulmonary disease; meningoencephalitis,
eye disease in BD; rapidly progressive hearing loss in CS), begin
“pulse” corticosteroids (eg, methylprednisolone, 1 g/d for 3 days)
■In MPA, ECV w/ severe progressive neuropathy, renal or severe pul-
monary disease, add cyclophosphamide, adjusting dose for WBC;
plasmapheresis sometimes also employed.
■In KD, aspirin or IV IgG, not corticosteroids
specific therapy
■Microscopic polyangiitis
➣Prednisone given initially & over the first 2–4 weeks then tapering;
cyclophosphamide may be necessary
■Polyarteritis nodosa, essential cryoglobulinemic vasculitis
➣As for MPA
➣Antiviral agents in hepatitis B, C-associated disease
■Cogan’s syndrome
➣Prednisone, w/ methotrexate added
■Limited cutaneous angiitis
➣Prednisone, w/ dapsone or cytotoxic agents
■Kawasaki’s disease
➣As outlined above under initial management
■Henoch-Schonlein purpura ̈
➣Most pts will do well w/ supportive care & NSAIDs
➣Corticosteroids may be required for nonsurgical GI problems &
cytotoxic agents for progressive renal disease
■Behc ̧et’s disease